BNP Paribas Downgrades Organon to Neutral, Raises Price Target to $14

Benzinga Newsdesk www.benzinga.com Positive 58.5%

Neg 0% Neu 0% Pos 58.5%

BNP Paribas analyst Navann Ty downgrades Organon (NYSE:OGN) from Outperform to Neutral and raises the price target from $12 to $14.